Process Optimization and Upscaling of Spray-Dried Drug-Amino acid Co-Amorphous Formulations

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Process Optimization and Upscaling of Spray-Dried Drug-Amino acid Co-Amorphous Formulations. / Kasten, Georgia; Duarte, Íris; Paisana, Maria; Löbmann, Korbinian; Rades, Thomas; Grohganz, Holger.

In: Pharmaceutics, Vol. 11, No. 1, 09.01.2019.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Kasten, G, Duarte, Í, Paisana, M, Löbmann, K, Rades, T & Grohganz, H 2019, 'Process Optimization and Upscaling of Spray-Dried Drug-Amino acid Co-Amorphous Formulations', Pharmaceutics, vol. 11, no. 1. https://doi.org/10.3390/pharmaceutics11010024

APA

Kasten, G., Duarte, Í., Paisana, M., Löbmann, K., Rades, T., & Grohganz, H. (2019). Process Optimization and Upscaling of Spray-Dried Drug-Amino acid Co-Amorphous Formulations. Pharmaceutics, 11(1). https://doi.org/10.3390/pharmaceutics11010024

Vancouver

Kasten G, Duarte Í, Paisana M, Löbmann K, Rades T, Grohganz H. Process Optimization and Upscaling of Spray-Dried Drug-Amino acid Co-Amorphous Formulations. Pharmaceutics. 2019 Jan 9;11(1). https://doi.org/10.3390/pharmaceutics11010024

Author

Kasten, Georgia ; Duarte, Íris ; Paisana, Maria ; Löbmann, Korbinian ; Rades, Thomas ; Grohganz, Holger. / Process Optimization and Upscaling of Spray-Dried Drug-Amino acid Co-Amorphous Formulations. In: Pharmaceutics. 2019 ; Vol. 11, No. 1.

Bibtex

@article{cf58da18b29b4b07947844b96a23fa78,
title = "Process Optimization and Upscaling of Spray-Dried Drug-Amino acid Co-Amorphous Formulations",
abstract = "The feasibility of upscaling the formulation of co-amorphous indomethacin-lysine from lab-scale to pilot-scale spray drying was investigated. A 2² full factorial design of experiments (DoE) was employed at lab scale. The atomization gas flow rate (Fatom, from 0.5 to 1.4 kg/h) and outlet temperature (Tout, from 55 to 75 °C) were chosen as the critical process parameters. The obtained amorphization, glass transition temperature, bulk density, yield, and particle size distribution were chosen as the critical quality attributes. In general, the model showed low Fatom and high Tout to be beneficial for the desired product characteristics (a co-amorphous formulation with a low bulk density, high yield, and small particle size). In addition, only a low Fatom and high Tout led to the desired complete co-amorphization, while a minor residual crystallinity was observed with the other combinations of Fatom and Tout. Finally, upscaling to a pilot scale spray dryer was carried out based on the DoE results; however, the drying gas flow rate and the feed flow rate were adjusted to account for the different drying chamber geometries. An increased likelihood to achieve complete amorphization, because of the extended drying chamber, and hence an increased residence time of the droplets in the drying gas, was found in the pilot scale, confirming the feasibility of upscaling spray drying as a production technique for co-amorphous systems.",
author = "Georgia Kasten and {\'I}ris Duarte and Maria Paisana and Korbinian L{\"o}bmann and Thomas Rades and Holger Grohganz",
year = "2019",
month = jan,
day = "9",
doi = "10.3390/pharmaceutics11010024",
language = "English",
volume = "11",
journal = "Pharmaceutics",
issn = "1999-4923",
publisher = "MDPI AG",
number = "1",

}

RIS

TY - JOUR

T1 - Process Optimization and Upscaling of Spray-Dried Drug-Amino acid Co-Amorphous Formulations

AU - Kasten, Georgia

AU - Duarte, Íris

AU - Paisana, Maria

AU - Löbmann, Korbinian

AU - Rades, Thomas

AU - Grohganz, Holger

PY - 2019/1/9

Y1 - 2019/1/9

N2 - The feasibility of upscaling the formulation of co-amorphous indomethacin-lysine from lab-scale to pilot-scale spray drying was investigated. A 2² full factorial design of experiments (DoE) was employed at lab scale. The atomization gas flow rate (Fatom, from 0.5 to 1.4 kg/h) and outlet temperature (Tout, from 55 to 75 °C) were chosen as the critical process parameters. The obtained amorphization, glass transition temperature, bulk density, yield, and particle size distribution were chosen as the critical quality attributes. In general, the model showed low Fatom and high Tout to be beneficial for the desired product characteristics (a co-amorphous formulation with a low bulk density, high yield, and small particle size). In addition, only a low Fatom and high Tout led to the desired complete co-amorphization, while a minor residual crystallinity was observed with the other combinations of Fatom and Tout. Finally, upscaling to a pilot scale spray dryer was carried out based on the DoE results; however, the drying gas flow rate and the feed flow rate were adjusted to account for the different drying chamber geometries. An increased likelihood to achieve complete amorphization, because of the extended drying chamber, and hence an increased residence time of the droplets in the drying gas, was found in the pilot scale, confirming the feasibility of upscaling spray drying as a production technique for co-amorphous systems.

AB - The feasibility of upscaling the formulation of co-amorphous indomethacin-lysine from lab-scale to pilot-scale spray drying was investigated. A 2² full factorial design of experiments (DoE) was employed at lab scale. The atomization gas flow rate (Fatom, from 0.5 to 1.4 kg/h) and outlet temperature (Tout, from 55 to 75 °C) were chosen as the critical process parameters. The obtained amorphization, glass transition temperature, bulk density, yield, and particle size distribution were chosen as the critical quality attributes. In general, the model showed low Fatom and high Tout to be beneficial for the desired product characteristics (a co-amorphous formulation with a low bulk density, high yield, and small particle size). In addition, only a low Fatom and high Tout led to the desired complete co-amorphization, while a minor residual crystallinity was observed with the other combinations of Fatom and Tout. Finally, upscaling to a pilot scale spray dryer was carried out based on the DoE results; however, the drying gas flow rate and the feed flow rate were adjusted to account for the different drying chamber geometries. An increased likelihood to achieve complete amorphization, because of the extended drying chamber, and hence an increased residence time of the droplets in the drying gas, was found in the pilot scale, confirming the feasibility of upscaling spray drying as a production technique for co-amorphous systems.

U2 - 10.3390/pharmaceutics11010024

DO - 10.3390/pharmaceutics11010024

M3 - Journal article

C2 - 30634423

VL - 11

JO - Pharmaceutics

JF - Pharmaceutics

SN - 1999-4923

IS - 1

ER -

ID: 211903944